Skip to main content
. 2012 Jun 11;8:861–869. doi: 10.3762/bjoc.8.96

Scheme 3.

Scheme 3

Mutasynthetic biotransformation of proansamitocin derivatives 9a and 9b with AHBA(−) mutant A. pretiosum HGF073 (starting materials could be reisolated: 9a: 77% reisolated, 9b: 23% reisolated).